Sector Pharmaceuticals & Biotech. - Latest news, views and updates

SECTOR | 21 Oct 2024

Alembic Pharmaceuticals Gets US FDA Approval For Generic Diltiazem Capsules

NDTV Profit

These are therapeutically equivalent to the reference listed drug product, Dilacor XR Extended-Release Capsules, 120 mg, 180 mg, and 240 mg of Allergan Sales LLC, it added.

Pharmaceuticals & Biotech.

SECTOR | 21 Oct 2024

Sales across 14,000 Jan Aushadhi outlets touch Rs 1,000 cr mark in October

Business Standard

Sales of Jan Aushadhi outlets reached Rs 1,000 crore mark in October this year, a feat that was achieved in December 2023. Notably, Pharmaceuticals & Medical Devices Bureau of India (PMBI) had sold medicines worth Rs 200 crore in single month of September 2024. "This achievement highlights the growing trust and reliance of the people on affordable and quality medicines. This was possible only with the unwavering support of the citizens, who have embraced the initiative by purchasing medicines from over 14,000 Jan Aushadhi Kendras across the country," Ministry of Chemicals and Fertilisers said in a statement. The substantial growth is a testament to PMBI's commitment to making healthcare accessible and affordable for all by reducing out of pocket expenditure, it added. In the last 10 years, there has been a growth of more than 170 times in number of Jan Aushadhi outlets in the country. From 80 outlets in 2014, the number has increased to more than 14,000 outlets now, covering...

Pharmaceuticals & Biotech.

SECTOR | 16 Oct 2024

Pharma Sector To Report 11% Profit Growth In Second Quarter: Analysts

NDTV Profit

Here is the second-quarter earnings forecast of key pharmaceutical companies by various brokerages:

Pharmaceuticals & Biotech.

SECTOR | 13 Oct 2024

US and India can work together on mental health: Surgeon General Murthy

Business Standard

US Surgeon General Dr Vivek Murthy has said that mental health is an issue on which his country and India can work together, so that it not only benefits the two countries, but the entire world. He said it is time to prioritise and accelerate the work on mental health, because the consequences have been too high, and they will only get worse unless we make this issue a priority. "I'll just say this (mental health) is an issue where the US and India can work together, where we can learn from each other, where we can collaborate on programmes, where we can support each other, as we have in the past for six decades, on so many health issues," Murthy told reporters here on Friday. He said he was proud of the US-India health partnership for six decades, during which both countries have worked on smallpox, polio, HIV, tuberculosis and Covid-19, and many other health challenges. "This is a time for us to come together as two nations, to work on the issue of mental health, and the work tha

Pharmaceuticals & Biotech.

SECTOR | 11 Oct 2024

What's The US Medicare Deal & How Will It Impact Pharma Companies? I Nimish Mehta On Pharma Stocks

NDTV Profit

Pharmaceuticals & Biotech.

SECTOR | 09 Oct 2024

'India's pharma exports expected to remain strong amid global slowdown'

Business Standard

Exports of India's pharmaceutical and meditech sectors are expected to sustain the growth momentum in the ongoing fiscal despite a slowdown in the global economy, a senior government official said on Wednesday. With the government revving up support for drug development in India, as many as 16 blockbuster molecules targeted for a wide range of therapeutic areas, including cancer, diabetes, HIV and tuberculosis, are in the pipeline to be produced in India, Department of Pharmaceuticals, Secretary Arunish Chawla told reporters on the sidelines of CII Pharma and Life Sciences summit here. "We have been analysing the export trends in the recent data. Even though there is a general slowdown in exports globally, the good news is that the Indian pharmaceuticals, biotech, and bulk drug exports have grown double-digit over the last year," he said in response to a query on export prospects of the pharma industry amid a global slowdown. He further said,"In the first four months of this year, .

Pharmaceuticals & Biotech.

SECTOR | 07 Oct 2024

Here's why Natco Pharma share price gained over 4% on October 7; details

Business Standard

Natco Pharma share rose after the company announced that Mylan Pharmaceuticals Inc & Novo Nordisk have reached a settlement of the US patent litigation related to generic Ozempic (Semaglutide)